Uncommon EGFR mutations in lung adenocarcinomas: Clinical features and response to tyrosine kinase inhibitors

Journal article

Open access

Peer reviewed

A. Brindel, W. Althakfi, M. Barritault, P.-P. Bringuier, E. Watkin, J.-M. Maury, N. Girard and M. Brevet

Annals of oncology, Vol.29, pp.viii747-viii748

10/2018

PMID: 32138040

Files and links (1)

url

https://doi.org/10.1093/annonc/mdy424.072View

Published (Version of record) Open

1 Record Views

Title: Uncommon EGFR mutations in lung adenocarcinomas: Clinical features and response to tyrosine kinase inhibitors
Creators - without role: A. Brindel - Pathology, Groupement Hospitalier Est, Bron, France
W. Althakfi - King Saud University
M. Barritault - Centre Hospitalier Vétérinaire Frégis
P.-P. Bringuier - Centre Hospitalier Vétérinaire Frégis
E. Watkin - Pathology, Selas Cypath, Villeurbane, France
J.-M. Maury - Lille’s Cardiology Hospital
N. Girard - Institute Curie
M. Brevet - Pathology, Groupement Hospitalier Est, Bron, France
Publication Details: Annals of oncology, Vol.29, pp.viii747-viii748
Publisher: Elsevier Ltd
Identifiers: 9952062308331
Academic Unit: King Saud University
Language: English
Resource Type: Journal article